A Phase II, Multicenter, Open-Label Trial Of The Safety And Efficacy Of Tarceva (Erlotinib Hydrochloride) In Patients With First Relapse Of Grade IV Glioma (Glioblastoma Multiforme)
Latest Information Update: 03 Nov 2021
Price :
$35 *
At a glance
- Drugs Erlotinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Genentech
- 24 Sep 2005 New trial record.